83 related articles for article (PubMed ID: 11350157)
1. Inclusion Behavior of 4-Nonylphenol into Cyclodextrin Derivatives.
Kawasaki N; Araki M; Nakamura T; Tanada S
J Colloid Interface Sci; 2001 Jun; 238(1):215-218. PubMed ID: 11350157
[TBL] [Abstract][Full Text] [Related]
2. Removal of Aromatic Hydrocarbon Compounds by Hydroxypropyl-cyclodextrin.
Tanada S; Nakamura T; Kawasaki N; Torii Y; Kitayama S
J Colloid Interface Sci; 1999 Sep; 217(2):417-419. PubMed ID: 10469551
[TBL] [Abstract][Full Text] [Related]
3. [Dissolution of nimodipine in an aqueous solution of hydroxyethyl-beta-cyclodextrin and a review of solubility of nimodipine with cyclodextrins].
Kopecký F; Kopecká B; Kaclík P
Ceska Slov Farm; 2003 Jan; 52(1):33-8. PubMed ID: 12685332
[TBL] [Abstract][Full Text] [Related]
4. [Solubilization and complexation of the antileukotrienic drug Quinlukast in aqueous solutions of cyclodextrins].
Kopecký F; Kopecká B
Ceska Slov Farm; 2005 May; 54(3):137-40. PubMed ID: 15945461
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
Yap KL; Liu X; Thenmozhiyal JC; Ho PC
Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
[TBL] [Abstract][Full Text] [Related]
6. Study on the complexation of isoquercitrin with beta-cyclodextrin and its derivatives by spectroscopy.
Wang Y; Qiao X; Li W; Zhou Y; Jiao Y; Yang C; Dong C; Inoue Y; Shuang S
Anal Chim Acta; 2009 Sep; 650(1):124-30. PubMed ID: 19720183
[TBL] [Abstract][Full Text] [Related]
7. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
8. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
Koontz JL; Marcy JE
J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
[TBL] [Abstract][Full Text] [Related]
9. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
Holvoet C; Heyden YV; Plaizier-Vercammen J
Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403
[TBL] [Abstract][Full Text] [Related]
10. Preparation and spectral investigation of inclusion complex of caffeic acid with hydroxypropyl-beta-cyclodextrin.
Zhang M; Li J; Zhang L; Chao J
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jan; 71(5):1891-5. PubMed ID: 18722807
[TBL] [Abstract][Full Text] [Related]
11. Improvement of steroid biotransformation with hydroxypropyl-beta-cyclodextrin induced complexation.
Zhang L; Wang M; Shen Y; Ma Y; Luo J
Appl Biochem Biotechnol; 2009 Dec; 159(3):642-54. PubMed ID: 19189059
[TBL] [Abstract][Full Text] [Related]
12. Chiral separation of N-imidazole derivatives, aromatase inhibitors, by cyclodextrin-capillary zone electrophoresis. Mechanism of enantioselective recognition.
Foulon C; Danel C; Vaccher MP; Bonte JP; Vaccher C; Goossens JF
Electrophoresis; 2004 Aug; 25(16):2735-44. PubMed ID: 15352005
[TBL] [Abstract][Full Text] [Related]
13. Comparative study on the inclusion behavior between meso-tetrakis(4-N-ethylpyridiniurmyl)porphyrin and beta-cyclodextrin derivatives.
Xiliang G; Shaomin S; Chuan D; Feng F; Wong MS
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(3):413-8. PubMed ID: 15582808
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
15. Improvement of antifungal activity of 10-undecyn-1-ol by inclusion complexation with cyclodextrin derivatives.
Neoh TL; Tanimoto T; Ikefuji S; Yoshii H; Furuta T
J Agric Food Chem; 2008 May; 56(10):3699-705. PubMed ID: 18454543
[TBL] [Abstract][Full Text] [Related]
16. Study on the inclusion behavior between meso-tetrakis[4-(3-pyridiniumpropoxy)phenyl]prophyrin tetrakisbromide and beta-cyclodextrin derivatives in aqueous solution.
Qiu WG; Li ZF; Bai GM; Meng SN; Dai HX; He H
Spectrochim Acta A Mol Biomol Spectrosc; 2007 Apr; 66(4-5):1189-93. PubMed ID: 17251055
[TBL] [Abstract][Full Text] [Related]
17. Study of the interaction between hydroxymethylnitrofurazone and 2-hydroxypropyl-beta-cyclodextrin.
Grillo R; de Melo NF; Moraes CM; de Lima R; Menezes CM; Ferreira EI; Rosa AH; Fraceto LF
J Pharm Biomed Anal; 2008 Jun; 47(2):295-302. PubMed ID: 18289821
[TBL] [Abstract][Full Text] [Related]
18. Degradation of pentachlorophenol in contaminated soil suspensions by potassium monopersulfate catalyzed oxidation by a supramolecular complex between tetra(p-sulfophenyl)porphineiron(III) and hydroxypropyl-beta-cyclodextrin.
Fukushima M; Tatsumi K
J Hazard Mater; 2007 Jun; 144(1-2):222-8. PubMed ID: 17101215
[TBL] [Abstract][Full Text] [Related]
19. Complexation study of brilliant cresyl blue with beta-cyclodextrin and its derivatives by UV-vis and fluorospectrometry.
Zhang QF; Jiang ZT; Guo YX; Li R
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jan; 69(1):65-70. PubMed ID: 17433764
[TBL] [Abstract][Full Text] [Related]
20. Suppression of estrogenic activity of 17-beta-estradiol by beta-cyclodextrin.
Oishi K; Toyao K; Kawano Y
Chemosphere; 2008 Dec; 73(11):1788-92. PubMed ID: 18840390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
